Stay updated on Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The screenshots show cosmetic formatting updates and minor textual edits that do not modify the study's core details (interventions, eligibility, endpoints, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:08:20.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    2%
    Check dated 2025-10-05T10:03:54.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Core content and terminology related to immune biology have been expanded (new terms added) and the version updated from v3.0.2 to v3.1.0.
    Difference
    0.9%
    Check dated 2025-09-28T03:15:55.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Updated Revision from v3.0.1 to v3.0.2 and removed the Back to Top link.
    Difference
    0.1%
    Check dated 2025-09-13T16:49:04.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T14:08:48.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as a comprehensive list of related medical topics, while removing several previous location details and resources.
    Difference
    2%
    Check dated 2025-08-30T11:05:47.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.